Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?
- 16 July 2016
- journal article
- review article
- Published by Springer Nature in Immunologic Research
- Vol. 65 (1) , 230-241
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Antiphospholipid syndrome and the brain in pediatric and adult patientsLupus, 2010
- Migraine and cardiovascular disease: systematic review and meta-analysisBMJ, 2009
- Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: The population-based MRI CAMERA studyCephalalgia, 2009
- Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patientsNeurological Sciences, 2002
- Patients With Acenocoumarol Treatment and MigraineHeadache: The Journal of Head and Face Pain, 2000
- Migrainous Stroke and the Antiphospholipid AntibodiesEuropean Neurology, 1994
- Anticardiolipin antibodies, a disease marker for ischemic cerebrovascular events in a younger patient population?Acta Neurologica Scandinavica, 1992
- Migraine and the Lupus Anticoagulant: Case Reports and Review of the LiteratureCephalalgia, 1987
- Anticardiolipin antibodies in autoimmune thrombocytopenic purpuraBritish Journal of Haematology, 1985
- Connective tissue disease and the skinClinical and Experimental Dermatology, 1984